Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara-vectored ebola vaccines at 1 year
The Ebola virus vaccine strategies evaluated by the WHO in response to the recent outbreak in West Africa included a heterologous prime/boost schedule of the adenovirus type 26 vector vaccine encoding Ebola virus glycoprotein (Ad26.ZEBOV) and the modified vaccinia virus Ankara vector vaccine, encodi...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
American Medical Association
2017
|